• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究 nesfatin-1 对肥胖大鼠胃功能的影响。

Study of the effects of nesfatin-1 on gastric function in obese rats.

机构信息

Guo-Tao Yang, Ai-Qin Dong, Department of Third Neurology, Cangzhou Central Hospital, Cangzhou Clinical Medical School of Hebei Medical University, Cangzhou 061001, Hebei Province, China.

出版信息

World J Gastroenterol. 2017 Apr 28;23(16):2940-2947. doi: 10.3748/wjg.v23.i16.2940.

DOI:10.3748/wjg.v23.i16.2940
PMID:28522911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5413788/
Abstract

AIM

To investigate the effects of nesfatin-1 on gastric function in obese rats.

METHODS

The obese rat model was induced by a high-fat diet. The gastric emptying rate and gastric acid secretory capacity of the rats were determined after treatment with different drug concentrations of nesfatin-1 and administration routes. Based on this, the expression of H+/K+-ATPase was measured using RT-PCR and western blot to preliminarily explore the mechanism of gastric acid secretion changes.

RESULTS

Body weight, body length, and Lee's index of the rats significantly increased in the high-fat diet-induced obese rat model. Two hours after lateral intracerebroventricular injection of nesfatin-1, the gastric emptying rate and gastric acid secretory capacity of rats decreased. Four hours after injection, both were restored to normal levels. In addition, the expression of H+/K+-ATPase decreased and moved in line with changes in gastric acid secretory capacity. This experiment revealed that intracerebroventricular injection of nesfatin-1, rather than intravenous injection, could suppress gastric function in obese rats. Moreover, its effect on the gastric emptying and gastric acid secretory capacity of rats is dose-dependent within a certain period of time.

CONCLUSION

Through this research, we provide a theoretical basis for further studies on nesfatin-1, a potential anti-obesity drug.

摘要

目的

研究内脂素-1 对肥胖大鼠胃功能的影响。

方法

采用高脂饮食诱导肥胖大鼠模型,给予不同浓度的内脂素-1 及不同给药途径,检测大鼠胃排空率和胃酸分泌量,在此基础上通过 RT-PCR 和 Western blot 检测 H+/K+-ATPase 的表达,初步探讨胃酸分泌变化的机制。

结果

高脂饮食诱导肥胖大鼠模型大鼠体重、体长和 Lee 指数明显增加。侧脑室注射内脂素-1 2 h 后,大鼠胃排空率和胃酸分泌量降低,4 h 后恢复正常水平。此外,H+/K+-ATPase 的表达降低,与胃酸分泌量的变化一致。本实验揭示了侧脑室注射内脂素-1 而非静脉注射可以抑制肥胖大鼠的胃功能,而且在一定时间内,其对大鼠胃排空和胃酸分泌的作用呈剂量依赖性。

结论

通过这项研究,为进一步研究内脂素-1作为一种潜在的抗肥胖药物提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/2ec8c118d421/WJG-23-2940-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/4fad4a9fc9ff/WJG-23-2940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/03427fc9548f/WJG-23-2940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/1b0cce385ead/WJG-23-2940-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/2ec8c118d421/WJG-23-2940-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/4fad4a9fc9ff/WJG-23-2940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/03427fc9548f/WJG-23-2940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/1b0cce385ead/WJG-23-2940-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df3/5413788/2ec8c118d421/WJG-23-2940-g004.jpg

相似文献

1
Study of the effects of nesfatin-1 on gastric function in obese rats.研究 nesfatin-1 对肥胖大鼠胃功能的影响。
World J Gastroenterol. 2017 Apr 28;23(16):2940-2947. doi: 10.3748/wjg.v23.i16.2940.
2
Impact of intracerebroventricular obestatin on plasma acyl ghrelin, des-acyl ghrelin and nesfatin-1 levels, and on gastric emptying in rats.室管膜内奥曲肽对大鼠血浆酰基胃饥饿素、去酰基胃饥饿素和 nesfatin-1 水平及胃排空的影响。
Mol Med Rep. 2012 Jul;6(1):191-6. doi: 10.3892/mmr.2012.901. Epub 2012 May 3.
3
Expression of gastrointestinal nesfatin-1 and gastric emptying in ventromedial hypothalamic nucleus- and ventrolateral hypothalamic nucleus-lesioned rats.腹内侧下丘脑核和腹外侧下丘脑核损伤大鼠胃肠道nesfatin-1的表达及胃排空情况
World J Gastroenterol. 2014 Jun 14;20(22):6897-905. doi: 10.3748/wjg.v20.i22.6897.
4
Nesfatin-1 Injected Intracerebroventricularly Increases Anxiety, Depression-Like Behavior, and Anhedonia in Normal Weight Rats.脑室注射 nesfatin-1 可增加正常体重大鼠的焦虑、抑郁样行为和快感缺失。
Nutrients. 2018 Dec 3;10(12):1889. doi: 10.3390/nu10121889.
5
Identification of nesfatin-1 as a satiety molecule in the hypothalamus.在下丘脑将nesfatin-1鉴定为一种饱腹感分子。
Nature. 2006 Oct 12;443(7112):709-12. doi: 10.1038/nature05162. Epub 2006 Oct 1.
6
New satiety hormone nesfatin-1 protects gastric mucosa against stress-induced injury: mechanistic roles of prostaglandins, nitric oxide, sensory nerves and vanilloid receptors.新的饱腹感激素 nesfatin-1 可保护胃黏膜免受应激性损伤:前列腺素、一氧化氮、感觉神经和香草素受体的作用机制。
Peptides. 2013 Nov;49:9-20. doi: 10.1016/j.peptides.2013.07.017. Epub 2013 Aug 24.
7
AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1.Nesfatin-1对肝脏脂质代谢的AMPK依赖性调节作用
Mol Cell Endocrinol. 2015 Dec 5;417:20-6. doi: 10.1016/j.mce.2015.09.006. Epub 2015 Sep 9.
8
The effects of nesfatin-1 in the paraventricular nucleus on gastric motility and its potential regulation by the lateral hypothalamic area in rats.神经肽Y衍生肽-1在大鼠室旁核中对胃动力的影响及其受下丘脑外侧区的潜在调控
J Neurochem. 2015 Feb;132(3):266-75. doi: 10.1111/jnc.12973. Epub 2014 Nov 18.
9
Nesfatin-1/NUCB2 in the amygdala influences visceral sensitivity via glucocorticoid and mineralocorticoid receptors in male maternal separation rats.杏仁核中的Nesfatin-1/NUCB2通过糖皮质激素和盐皮质激素受体影响雄性母婴分离大鼠的内脏敏感性。
Neurogastroenterol Motil. 2016 Oct;28(10):1545-53. doi: 10.1111/nmo.12853. Epub 2016 Jul 5.
10
Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats.内脂素-1 通过中枢迷走神经机制抑制大鼠胃酸分泌。
Am J Physiol Gastrointest Liver Physiol. 2012 Sep 1;303(5):G570-7. doi: 10.1152/ajpgi.00178.2012. Epub 2012 Jun 21.

引用本文的文献

1
Efficacy of Fetal Wharton's Jelly Mesenchymal Stem Cells-Derived Small Extracellular Vesicles in Metabolic Syndrome.胎儿华通氏胶间充质干细胞衍生的小细胞外囊泡在代谢综合征中的疗效
Biomolecules. 2025 Jan 1;15(1):44. doi: 10.3390/biom15010044.
2
Effect of glutamine use on the formation of intestinal neomucosa on peritoneal surface in rats.谷氨酰胺使用对大鼠腹膜表面肠黏膜新生形成的影响。
Ulus Travma Acil Cerrahi Derg. 2022 Nov;28(11):1541-1548. doi: 10.14744/tjtes.2022.36903.
3
Effects of combination of obesity, diabetes, and hypoxia on inflammatory regulating genes and cytokines in rat pancreatic tissues and serum.

本文引用的文献

1
Prevalence of obesity and acanthosis nigricans among young children in the children's healthy living program in the United States Affiliated Pacific.美国附属太平洋地区儿童健康生活项目中幼儿肥胖和黑棘皮病的患病率
Medicine (Baltimore). 2016 Sep;95(37):e4711. doi: 10.1097/MD.0000000000004711.
2
Metabolism rather than obesity is associated with ischemic stroke: a cross-sectional study in rural Northeastern China.代谢而非肥胖与缺血性卒中相关:中国东北农村地区的一项横断面研究。
Springerplus. 2016 Aug 25;5(1):1419. doi: 10.1186/s40064-016-3088-2. eCollection 2016.
3
Obesity and the association with maternal mental health symptoms.
肥胖、糖尿病和缺氧对大鼠胰腺组织和血清中炎症调节基因和细胞因子的影响。
PeerJ. 2022 Oct 4;10:e13990. doi: 10.7717/peerj.13990. eCollection 2022.
4
Curcumin Enhanced the Neomucosa Formation by Mediating the Antioxidation Mechanism in Rats.姜黄素通过介导大鼠抗氧化机制增强新黏膜形成。
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):154-160. doi: 10.14744/SEMB.2021.01878. eCollection 2022.
5
"Sibling" battle or harmony: crosstalk between nesfatin-1 and ghrelin.“兄弟姐妹”之战或和谐:内脂素-1 与胃饥饿素的串扰。
Cell Mol Life Sci. 2022 Mar 3;79(3):169. doi: 10.1007/s00018-022-04193-6.
6
Physiological and histopathological effects of electroporation pulse on stomach of rats.电穿孔脉冲对大鼠胃的生理和组织病理学影响。
BMC Gastroenterol. 2021 Sep 23;21(1):351. doi: 10.1186/s12876-021-01924-0.
7
High-fat Diet Enhances Gastric Contractility, but Abolishes Nesfatin-1-induced Inhibition of Gastric Emptying.高脂饮食增强胃收缩性,但消除了Nesfatin-1诱导的胃排空抑制作用。
J Neurogastroenterol Motil. 2021 Apr 30;27(2):265-278. doi: 10.5056/jnm20206.
8
Diet-induced obesity in animal models: points to consider and influence on metabolic markers.动物模型中的饮食诱导肥胖:需考虑的要点及对代谢标志物的影响
Diabetol Metab Syndr. 2021 Mar 18;13(1):32. doi: 10.1186/s13098-021-00647-2.
9
Current Understanding of the Role of Nesfatin-1.对Nesfatin-1作用的当前认识。
J Endocr Soc. 2018 Sep 10;2(10):1188-1206. doi: 10.1210/js.2018-00246. eCollection 2018 Oct 1.
10
Novel transmitters in brain stem vagal neurocircuitry: new players on the pitch.脑干迷走神经神经回路中的新型递质:球场上的新球员。
Am J Physiol Gastrointest Liver Physiol. 2018 Jul 1;315(1):G20-G26. doi: 10.1152/ajpgi.00059.2018. Epub 2018 Mar 29.
肥胖及其与孕产妇心理健康症状的关联。
J Matern Fetal Neonatal Med. 2017 Aug;30(16):1897-1901. doi: 10.1080/14767058.2016.1229766. Epub 2017 Apr 10.
4
Hypertension and Obesity in Dakar, Senegal.塞内加尔达喀尔的高血压与肥胖问题
PLoS One. 2016 Sep 13;11(9):e0161544. doi: 10.1371/journal.pone.0161544. eCollection 2016.
5
Defining "Success" in Childhood Obesity Interventions in Primary Care.界定初级保健中儿童肥胖干预措施的“成功”标准。
Pediatrics. 2016 Oct;138(4). doi: 10.1542/peds.2016-2497. Epub 2016 Sep 12.
6
Origins and early development of the concept that brown adipose tissue thermogenesis is linked to energy balance and obesity.棕色脂肪组织产热与能量平衡及肥胖相关这一概念的起源和早期发展
Biochimie. 2017 Mar;134:62-70. doi: 10.1016/j.biochi.2016.09.007. Epub 2016 Sep 10.
7
KBH-1, an herbal composition, improves hepatic steatosis and leptin resistance in high-fat diet-induced obese rats.KBH-1是一种草药组合物,可改善高脂饮食诱导的肥胖大鼠的肝脂肪变性和瘦素抵抗。
BMC Complement Altern Med. 2016 Sep 13;16(1):355. doi: 10.1186/s12906-016-1265-z.
8
Overweight and Obesity in Young Adulthood and the Risk of Stroke: a Meta-analysis.青年期超重与肥胖及中风风险:一项荟萃分析。
J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2995-3004. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.018. Epub 2016 Sep 8.
9
Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour.肠道微生物群在宿主食欲控制中的作用:细菌生长与动物摄食行为。
Nat Rev Endocrinol. 2017 Jan;13(1):11-25. doi: 10.1038/nrendo.2016.150. Epub 2016 Sep 12.
10
The prevalence of obesity and influence of early life and behavioral factors on obesity in Chinese children in Guangzhou.广州中国儿童肥胖的患病率以及早期生活和行为因素对肥胖的影响。
BMC Public Health. 2016 Sep 9;16(1):954. doi: 10.1186/s12889-016-3599-3.